Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?

Gut Liver. 2023 Jan 15;17(1):10-11. doi: 10.5009/gnl220542.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Bile Duct Neoplasms* / pathology
  • Bile Duct Neoplasms* / surgery
  • Bile Ducts, Intrahepatic
  • Biomarkers
  • Biomarkers, Tumor
  • Cholangiocarcinoma* / surgery
  • Humans
  • Immunohistochemistry
  • Prognosis

Substances

  • Biomarkers
  • Biomarkers, Tumor